Author information:
(1)Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology 
Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of 
Medicine, Nashville, Tennessee.
(2)Centre for Cancer Genetic Epidemiology, Department of Public Health and 
Primary Care, University of Cambridge, Cambridge, United Kingdom.
(3)Centre for Cancer Genetic Epidemiology, Department of Oncology, University of 
Cambridge, Cambridge, United Kingdom.
(4)Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, 
Australia. Centre for Epidemiology and Biostatistics, School of Population and 
Global health, The University of Melbourne, Melbourne, Victoria, Australia.
(5)Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, 
Australia.
(6)Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, 
Canada. Department of Molecular Genetics, University of Toronto, Toronto, 
Canada.
(7)Department of Epidemiology, University of California Irvine, Irvine, 
California.
(8)Division of Clinical Epidemiology and Aging Research, German Cancer Research 
Center, Heidelberg, Germany.
(9)Department of Gynaecology and Obstetrics, University Hospital Erlangen, 
Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
(10)Human Cancer Genetics Program, Spanish National Cancer Research Centre, 
Madrid, Spain. Centro de Investigación en Red de Enfermedades Raras, Valencia, 
Spain.
(11)Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology 
Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of 
Medicine, Nashville, Tennessee. International Epidemiology Institute, Rockville, 
Maryland.
(12)Department of Radiation Oncology, Hannover Medical School, Hannover, 
Germany.
(13)Copenhagen General Population Study, Herlev Hospital, Herlev, Denmark. 
Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University 
Hospital, Herlev, Denmark. Faculty of Health and Medical Sciences, University of 
Copenhagen, Copenhagen, Denmark.
(14)Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, 
Germany. University of Tübingen, Tübingen, Germany. German Cancer Consortium, 
German Cancer Research Center, Heidelberg, Germany.
(15)Division of Clinical Epidemiology and Aging Research, German Cancer Research 
Center, Heidelberg, Germany. German Cancer Consortium, German Cancer Research 
Center, Heidelberg, Germany. Division of Preventive Oncology, German Cancer 
Research Center (DKFZ), Heidelberg, Germany.
(16)Division of Cancer Epidemiology and Genetics, National Cancer Institute, 
Rockville, Maryland.
(17)Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, 
the Netherlands.
(18)Institute for Prevention and Occupational Medicine of the German Social 
Accident Insurance, Bochum, Germany.
(19)Division of Molecular Genetic Epidemiology, German Cancer Research Center, 
Heidelberg, Germany. Molecular Epidemiology Group, German Cancer Research 
Center, Heidelberg, Germany.
(20)Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, 
Germany.
(21)Department of Biomedical Sciences, Seoul National University College of 
Medicine, Seoul, Korea. Cancer Research Institute, Seoul National University 
College of Medicine, Seoul, Korea.
(22)Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, 
Minnesota.
(23)Sheffield Cancer Research Centre, Department of Oncology, University of 
Sheffield, Sheffield, United Kingdom.
(24)Academic Unit of Pathology, Department of Neuroscience, University of 
Sheffield, Sheffield, United Kingdom.
(25)Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
Stockholm, Sweden.
(26)Department of Pathology, Leiden University Medical Center, Leiden, the 
Netherlands. Department of Human Genetics, Leiden University Medical Center, 
Leiden, the Netherlands.
(27)Centre Hospitalier Universitaire de Québec Research Center, Laval 
University, Québec, Canada.
(28)Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
(29)Department of Gynaecology and Obstetrics, University Hospital Erlangen, 
Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. David 
Geffen School of Medicine, Department of Medicine, Division of Hematology and 
Oncology, University of California at Los Angeles, Los Angeles, California.
(30)Division of Cancer Studies, Breakthrough Breast Cancer Research Centre, 
Institute of Cancer Research, London, United Kingdom.
(31)Department of Breast Surgery, Herlev Hospital, Copenhagen University 
Hospital, Herlev, Denmark.
(32)Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific 
Research "Demokritos", Athens, Greece.
(33)International Agency for Research on Cancer, Lyon, France.
(34)Division of Cancer Studies, Breakthrough Breast Cancer Research Centre, 
Institute of Cancer Research, London, United Kingdom. Division of Genetics and 
Epidemiology, Institute of Cancer Research, London, United Kingdom.
(35)Department of Surgery, Oulu University Hospital and University of Oulu, 
Oulu, Finland.
(36)Environmental Epidemiology of Cancer, Center for Research in Epidemiology 
and Population Health, INSERM, Villejuif, France. University Paris-Sud, 
Villejuif, France.
(37)Department of Preventive Medicine, Keck School of Medicine, University of 
Southern California, Los Angeles, California.
(38)Molecular Genetics of Breast Cancer, German Cancer Research Center, 
Heidelberg, Germany.
(39)Saw Swee Hock School of Public Health, National University of Singapore, 
Singapore, Singapore. Department of Surgery, National University Health System, 
Singapore.
(40)Department of Medical Oncology, Erasmus University Medical Center, 
Rotterdam, the Netherlands.
(41)Centre for Epidemiology and Biostatistics, School of Population and Global 
health, The University of Melbourne, Melbourne, Victoria, Australia.
(42)Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
(43)Division of Epidemiology and Prevention, Aichi Cancer Center Research 
Institute, Aichi, Japan.
(44)Department of Genetics and Pathology, Pomeranian Medical University, 
Szczecin, Poland.
(45)Department of Biomedical Sciences, Seoul National University College of 
Medicine, Seoul, Korea. Cancer Research Institute, Seoul National University 
College of Medicine, Seoul, Korea. Department of Preventive Medicine, Seoul 
National University College of Medicine, Seoul, Korea.
(46)Department of Obstetrics and Gynecology, Helsinki University Central 
Hospital, University of Helsinki, Helsinki, Finland.
(47)Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research 
Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. Division of 
Epidemiology, Dalla Lana School of Public Health, University of Toronto, 
Toronto, Ontario, Canada.
(48)School of Medicine, Institute of Clinical Medicine, Pathology and Forensic 
Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, 
Kuopio, Finland; Imaging Center, Department of Clinical Pathology, Kuopio 
University Hospital, Kuopio, Finland.
(49)Vesalius Research Center, Leuven, Belgium. Laboratory for Translational 
Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
(50)University of Hawaii Cancer Center, Honolulu, Hawaii.
(51)Department of Molecular Medicine and Surgery, Karolinska Institutet, 
Stockholm, Sweden.
(52)Division of Health Sciences, Warwick Medical School, Warwick University, 
Coventry, United Kingdom.
(53)Unit of Medical Genetics, Department of Preventive and Predictive Medicine, 
Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
(54)Department of Oncology - Pathology, Karolinska Institutet, Stockholm, 
Sweden.
(55)National Center for Tumor Diseases, University of Heidelberg, Heidelberg, 
Germany. Department of Obstetrics and Gynecology, University of Heidelberg, 
Heidelberg, Germany.
(56)Department of Preventive Medicine, Kyushu University Faculty of Medical 
Sciences, Fukuoka, Japan.
(57)Anatomical Pathology, The Alfred Hospital, Melbourne, Victoria, Australia.
(58)Division of Gynaecology and Obstetrics, Technische Universität München, 
Munich, Germany.
(59)Unit of Medical Genetics, Department of Preventive and Predictive Medicine, 
Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy. Institute of 
Population Health, University of Manchester, Manchester, United Kingdom.
(60)Beckman Research Institute of City of Hope, Duarte, California.
(61)Department of Genetics, Institute for Cancer Research, Oslo University 
Hospital, Radiumhospitalet, Ullernchausseen, Oslo, Norway. K.G. Jebsen Center 
for Breast Cancer Research, Institute for Clinical Medicine, Faculty of 
Medicine, University of Oslo, Kirkeveien, Oslo, Norway.
(62)Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
(63)Division of Breast Cancer Research, Institute of Cancer Research, London, 
United Kingdom; Cancer Research, Institute of Cancer Research, London, United 
Kingdom.
(64)IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
(65)Department of Pathology, National University Health System, Singapore.
(66)National Cancer Institute, Bangkok, Thailand.
(67)Research Oncology, Guy's Hospital, King's College London, London, United 
Kingdom.
(68)Division of Molecular Gyneco-Oncology, Department of Gynaecology and 
Obstetrics, University Hospital of Cologne, Cologne, Germany. Center for 
Integrated Oncology, University Hospital of Cologne, Cologne, Germany. Center 
for Molecular Medicine, University Hospital of Cologne, Cologne, Germany. Center 
of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, 
Germany.
(69)School of Public Health, China Medical University, Taichung, Taiwan. Taiwan 
Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
(70)Department of Pathology, The University of Melbourne, Melbourne, Victoria, 
Australia.
(71)Division of Genetics and Epidemiology and Division of Breast Cancer 
Research, Institute of Cancer Research, London, United Kingdom.
(72)Cancer Research Initiatives Foundation, Subang Jaya, Selangor, Malaysia. 
Breast Cancer Research Unit, Cancer Research Institute, University Malaya 
Medical Centre, Kuala Lumpur, Malaysia.
(73)Department of Molecular Virology, Immunology, and Medical Genetics, 
Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
(74)Department of Surgical Oncology, Leiden University Medical Center, Leiden, 
the Netherlands.
(75)Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research 
Centre, University of Oxford, Oxford, United Kingdom.
(76)Department of Clinical Genetics, Erasmus University Medical Center, 
Rotterdam, the Netherlands.
(77)Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical 
Chemistry, University of Oulu, Oulu, Finland. Laboratory of Cancer Genetics and 
Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu, Finland.
(78)Breast Cancer Research Unit, Cancer Research Institute, University Malaya 
Medical Centre, Kuala Lumpur, Malaysia.
(79)Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain.
(80)Shanghai Municipal Center for Disease Control and Prevention, Shanghai, PR 
China.
(81)Centre for Cancer Genetic Epidemiology, Department of Public Health and 
Primary Care, University of Cambridge, Cambridge, United Kingdom. Centre for 
Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 
Cambridge, United Kingdom.
(82)Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology 
Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of 
Medicine, Nashville, Tennessee. wei.zheng@vanderbilt.edu.